Estrogen Dominance: Symptoms, Causes, Testing, and Functional Medicine Treatment
Why Estrogen Dominance Is More Than “High Estrogen”
Anxiety that worsens around your menstrual cycle.
Periods that are consistently heavy, irregular, or increasingly symptomatic.
PMS that feels disruptive rather than mildly uncomfortable.
Hormonal symptoms can fluctuate across the menstrual cycle, but progressively heavier bleeding, worsening PMS, new cycle irregularity, sleep disruption, migraines, anxiety, or breast tenderness deserve a closer look—especially when several begin occurring together. In clinical practice, the pattern often tells us more than an isolated hormone value.
One common functional hormone pattern is estrogen dominance, in which estrogenic activity is excessive relative to progesterone, estrogen exposure remains prolonged without adequate progesterone opposition, or estrogen metabolism and elimination are impaired.
Estrogen dominance does not necessarily mean that circulating estradiol is abnormally high. It can reflect several distinct physiological patterns, including relative progesterone insufficiency, chronic or inconsistent anovulation, increased endogenous or exogenous estrogen exposure, altered estrogen metabolism, and increased enterohepatic recycling (1,6,11).
Because estrogen receptors and hormone-sensitive pathways extend throughout the body, the resulting pattern can affect far more than the menstrual cycle, including mood, sleep, migraine susceptibility, breast symptoms, metabolic regulation, and bleeding patterns.
The more useful question is not simply whether estrogen is “high,” but what is changing estrogen exposure, progesterone production, hormone metabolism, and tissue response in that particular woman.
→ Hormone Imbalances in Women: Root Causes, Testing, and Integrative Treatment
What Is Estrogen?
Estrogen is often described primarily as a reproductive hormone, but its physiology extends far beyond reproduction. Estrogen is a systemic signaling hormone with receptors throughout the brain, breast tissue, bone, cardiovascular system, immune system, liver, adipose tissue, and reproductive organs (1,2).
Because estrogen receptors are distributed across so many tissues, changes in estrogen signaling can affect neurological function, mood, sleep, metabolism, inflammatory signaling, vascular function, and energy regulation as well as the menstrual cycle.
The Three Primary Forms of Estrogen
The three primary endogenous estrogens are estradiol, estrone, and estriol, each with different receptor activity, tissue effects, and patterns of production across the reproductive lifespan :
Estradiol (E2)
The predominant and most potent estrogen during the reproductive years. Estradiol is produced primarily by the ovaries and plays central roles in follicular development, ovulatory signaling, endometrial proliferation, bone remodeling, cardiovascular physiology, and brain function.Estrone (E1)
Estrone becomes the predominant circulating estrogen after menopause. It is produced largely through peripheral conversion of androgen precursors, particularly in adipose tissue, and remains biologically active despite having lower estrogen-receptor potency than estradiol.Estriol (E3)
Estriol rises markedly during pregnancy and is produced through coordinated fetal, placental, and maternal metabolism. It has substantially lower estrogen-receptor potency than estradiol but remains biologically active and contributes to tissue and immune signaling during pregnancy (1,2).
The clinically relevant question is not which estrogen is “good” or “bad,” but how much estrogenic exposure is occurring, which tissues are being stimulated, whether progesterone opposition is adequate, and how estrogen is being metabolized and eliminated.
Why Estrogen Balance Matters
Estrogen signaling is normally dynamic, cyclical, and tightly regulated. In the endometrium, estrogen stimulates proliferation during the follicular phase, while progesterone after ovulation changes that tissue response and supports secretory maturation. When estrogenic stimulation continues without adequate progesterone opposition, proliferative signaling can persist (3).
Outside the endometrium, estrogen effects depend on concentration, receptor subtype, tissue, reproductive stage, metabolic environment, and interactions with other hormones. Estrogen physiology therefore cannot be reduced to a simple “high versus low” model.
Estrogen dominance therefore cannot be understood from one isolated hormone value.
The underlying pattern may involve:
Increased estrogen exposure
Inadequate progesterone production
Inconsistent ovulation
Altered estrogen metabolism or elimination
Increased enterohepatic recycling
or several of these mechanisms occurring together.
What Does Estrogen Do for Your Body?
Estrogen’s effects extend far beyond the ovaries and menstrual cycle. Because estrogen receptors are distributed throughout the body, estrogen functions as a system-wide signaling hormone, influencing neurological, metabolic, immune, cardiovascular, skeletal, and reproductive physiology (4).
When estrogen signaling is appropriately timed and regulated, it supports normal function across multiple systems. When estrogen exposure becomes excessive, progesterone opposition is inadequate, ovulation becomes inconsistent, or estrogen metabolism shifts, symptoms can emerge across several systems at once.
Estrogen and Menstrual Cycle Regulation
Estradiol rises during the follicular phase, supporting follicular development, endometrial proliferation, and the neuroendocrine signaling that culminates in ovulation. After ovulation, progesterone changes the endometrial response from continued proliferation toward secretory maturation and provides an important hormonal counterbalance to estrogenic stimulation (3).
When ovulation is inconsistent or absent, progesterone production declines while estrogenic stimulation may continue. This can contribute to heavier or more symptomatic periods, worsening PMS, cycle irregularity, and other patterns commonly associated with estrogen dominance.
Estrogen, Mood, and Brain Function
Estradiol influences serotonergic, dopaminergic, noradrenergic, glutamatergic, and GABA-related signaling, while also affecting neuroplasticity, stress-response pathways, and cognitive function.
Rapid shifts in estrogen and progesterone across the menstrual cycle and during perimenopause can influence anxiety, irritability, mood stability, concentration, memory, and emotional reactivity (5). In many women, the rate and timing of hormonal change can be just as important as the absolute hormone concentration.
Estrogen and Sleep Regulation
Estrogen and progesterone interact with thermoregulation, neurotransmission, melatonin signaling, sleep architecture, and circadian physiology.
Changes in these hormones can affect sleep onset, nighttime waking, temperature regulation, and sleep quality. Low or inconsistent progesterone can also reduce the influence of progesterone-derived neuroactive metabolites on GABAergic signaling, contributing to a more activated nervous system, lighter sleep, or increased nighttime anxiety (6).
These patterns often become more noticeable during the luteal phase, anovulatory cycles, and perimenopause.
Estrogen, Metabolism, and Blood Sugar
Estrogen influences insulin sensitivity, glucose uptake, adipocyte signaling, fat distribution, and mitochondrial energy metabolism (10).
The relationship between reproductive hormones and metabolic health is bidirectional. Insulin resistance can disrupt ovarian signaling and ovulation, while excess adipose tissue increases peripheral aromatase activity, converting androgen precursors into estrogens. Disrupted ovulation can then further reduce progesterone production and alter the estrogen–progesterone balance (7).
This helps explain why estrogen-dominant patterns frequently overlap with weight gain, cravings, blood sugar instability, fatigue, and difficulty losing weight despite no obvious change in diet or activity.
Estrogen and Immune Function
Estrogen modulates both innate and adaptive immune activity through estrogen receptors expressed on multiple immune-cell populations (8).
Its effects vary by concentration, receptor subtype, tissue, reproductive stage, and immune environment. Hormonal fluctuations can therefore influence inflammatory signaling, immune reactivity, mast-cell activity, and autoimmune expression differently across women and across different phases of life.
This is one reason hormone symptoms can intensify during periods of immune activation, chronic inflammation, major stress, or perimenopausal hormone fluctuation.
Estrogen and Cardiovascular Health
Estrogen influences endothelial function, vascular tone, nitric oxide signaling, lipid metabolism, and vascular inflammation (9).
During the reproductive years, estradiol contributes to normal vascular responsiveness and cardiometabolic regulation. As estrogen production and signaling change with age, perimenopause, menopause, metabolic dysfunction, or altered hormone balance, these cardiovascular effects also change.
This relationship is important because hormone balance cannot be separated from metabolic health, insulin sensitivity, inflammation, lipid metabolism, and vascular function.
Estrogen and Hormone-Sensitive Tissues
Estrogen regulates growth and signaling in hormone-responsive tissues, including the endometrium, breast tissue, ovaries, and other reproductive structures.
In the endometrium, prolonged estrogen exposure without adequate progesterone opposition promotes continued proliferation (3). In other hormone-sensitive tissues, estrogen interacts with progesterone, growth factors, inflammatory signaling, genetics, receptor expression, and local tissue metabolism to influence cellular behavior (3).
This is why the physiologic effects of estrogen cannot be reduced to simply having “too much” or “too little” estrogen.
How Estrogen Imbalance Creates Symptom Clusters
Because estrogen participates in so many interconnected systems, imbalance rarely presents as one isolated symptom. More often, women develop clusters of symptoms—for example, anxiety with poor sleep and migraines, or heavy periods with breast tenderness, fatigue, weight changes, and blood sugar instability.
A functional medicine evaluation therefore looks beyond whether estradiol is simply “high” or “normal.” The more useful questions are:
How much estrogenic activity is occurring?
Is progesterone opposition adequate?
Is ovulation occurring consistently?
How is estrogen being metabolized and methylated?
Is enterohepatic recycling increasing estrogen exposure?
Are metabolic dysfunction, gut imbalance, stress physiology, or environmental exposures contributing to the hormone pattern?
What Is Estrogen Dominance?
Estrogen dominance describes a functional hormone pattern in which estrogenic influence is excessive relative to progesterone or remains elevated because estrogen production, metabolism, recirculation, and elimination are out of balance (10).
The underlying physiology differs between women. One woman may have high estrogen production, another may have inadequate progesterone because she is not ovulating consistently, while another may have altered estrogen metabolism or increased enterohepatic recycling.
High Estrogen vs. Estrogen Dominance: What Is the Difference?
High estrogen means estrogen concentrations are elevated for the relevant age, cycle phase, or physiological context.
Unopposed estrogen refers more specifically to estrogenic stimulation—particularly of the endometrium—without adequate progesterone opposition (3).
Estrogen dominance is a broader functional pattern. Estrogen itself may be elevated, but the imbalance can also develop when progesterone is insufficient, ovulation is inconsistent, estrogen metabolism is altered, or estrogen is being recirculated rather than efficiently eliminated (10).
Why Estrogen Dominance Can Be Missed on Standard Hormone Testing
Standard hormone testing can miss estrogen-dominant patterns because estradiol and progesterone fluctuate substantially across the menstrual cycle, and a single blood draw does not show the full picture of estrogen production, progesterone output, ovulation, estrogen metabolites, or hormone clearance (11).
A functional hormone assessment looks at several pieces together:
Cycle timing and symptom patterns
Whether ovulation is occurring consistently
Luteal progesterone output
Age and perimenopausal changes
Estrone, estradiol, estriol, and estrogen metabolite patterns
Estrogen hydroxylation and methylation pathways
Gut-mediated enterohepatic recycling
Thyroid, prolactin, SHBG, and androgen balance
Insulin resistance and metabolic health
Liver function, bowel elimination, and nutrient status
Exogenous hormones and environmental endocrine exposures
A woman can therefore have significant hormone symptoms even when a single estradiol value falls within the laboratory reference range. The question is not simply whether estradiol is “normal,” but whether estrogen production, progesterone output, ovulation, metabolism, recirculation, and elimination are functioning in a balanced way.
How Estrogen Dominance Develops: Estrogen, Progesterone, Ovulation, and Clearance
Estrogen dominance can develop through several overlapping mechanisms. In many women, the problem is not simply excessive ovarian estrogen production, but a disruption in the relationship between estrogen production, ovulation, progesterone output, estrogen metabolism, elimination, and environmental estrogenic exposure.
These mechanisms frequently overlap, which is why two women with similar symptoms can have very different underlying hormone patterns.
1. Low Progesterone From Disrupted Ovulation
Progesterone production depends on successful ovulation and formation of the corpus luteum. When ovulation is delayed, inconsistent, or absent, luteal progesterone output falls even when estrogen production remains substantial (12).
Contributors to disrupted or inconsistent ovulation can include:
Perimenopausal changes in ovarian function
PCOS and insulin resistance (7,12)
Functional hypothalamic suppression from inadequate energy availability, excessive exercise, or significant stress
Thyroid dysfunction (13)
Hyperprolactinemia
Chronic illness
Significant weight change
In this pattern, estrogen itself does not have to be elevated. The imbalance develops because progesterone production is inadequate relative to ongoing estrogenic stimulation. Common patterns include worsening PMS, heavier or more symptomatic periods, breast tenderness, anxiety, sleep disruption, and hormonally triggered headaches despite an estradiol result that may appear unremarkable in isolation.
This becomes especially relevant during perimenopause, when ovulation can become increasingly inconsistent while estrogen production remains substantial or highly variable (14). The result can be repeated cycles of significant estrogenic stimulation without the usual luteal-phase progesterone response.
2. Altered Estrogen Metabolism and Elimination
Estrogen metabolism involves several coordinated biochemical steps. In the liver, estrone and estradiol undergo phase I hydroxylation, producing metabolites primarily through the 2-hydroxy, 4-hydroxy, and 16-hydroxy pathways (10). These metabolites then undergo phase II reactions—including methylation, glucuronidation, and sulfation—before elimination through urine or bile.
Estrogens secreted into bile can enter the intestine, where microbial enzymes such as β-glucuronidase and sulfatase can deconjugate them and allow active estrogens to be reabsorbed through enterohepatic circulation (15).
Factors that can alter estrogen metabolism and elimination include:
Impaired hepatic function or increased metabolic burden
Nutrient deficiencies affecting methylation and conjugation
Altered 2-hydroxy, 4-hydroxy, or 16-hydroxy estrogen metabolism
Reduced methylation of catechol estrogens (16)
Constipation or slow gastrointestinal transit
Dysbiosis and increased microbial deconjugation
Impaired bile flow or biliary elimination
Medications and exogenous hormones that alter estrogen production, metabolism, or clearance
When these pathways are impaired, estrogen can remain biologically active longer, less favorable metabolites can accumulate, or conjugated estrogens can be recirculated rather than eliminated. This can increase overall estrogenic exposure even when ovarian estrogen production itself is not excessive.
3. Xenoestrogens and Endocrine-Disrupting Chemical Exposure
Endocrine-disrupting chemicals can alter hormone signaling through multiple mechanisms, including:
Estrogen-receptor activation or blockade
Changes in hormone synthesis and metabolism
Disruption of hypothalamic-pituitary-ovarian signaling
Interference with normal endocrine feedback (17).
Environmental hormone exposure is an important part of a functional hormone assessment because exposure is cumulative and rarely involves a single compound. Repeated contact with estrogenic and other endocrine-disrupting chemicals can add to the hormonal burden the body must metabolize and regulate.
Common sources include:
Plastics and food packaging, including compounds such as bisphenols and phthalates
Pesticides and herbicides
Synthetic fragrances, cosmetics, and personal care products
Household cleaners and chemical coatings
Contaminated food and water
Occupational exposures
Certain medications and exogenous hormones
The clinical significance of these exposures depends on cumulative burden, timing, metabolism, genetics, detoxification capacity, and the presence of other hormone-disrupting factors such as insulin resistance, poor elimination, or low progesterone.
How Estrogen Dominance Mechanisms Interact
These mechanisms rarely operate in isolation. Insulin resistance, for example, can interfere with ovulation and reduce progesterone production while increased adipose aromatase activity increases peripheral estrogen production (7). Constipation or dysbiosis can increase enterohepatic estrogen recycling, while impaired methylation or conjugation can alter how estrogen metabolites are processed and eliminated (10,15,16).
Environmental endocrine exposure can add another layer of signaling burden on top of these endogenous mechanisms (17).
The important clinical question is therefore not simply whether estrogen is “high,” but where the imbalance is occurring:
Production
Ovulation
Progesterone output
Metabolism
Methylation
Recirculation
Elimination
Environmental exposure
—or several of these at once.
Symptoms of Estrogen Dominance
Estrogen dominance often presents as a cluster of cycle-related and systemic symptoms rather than one isolated complaint. Symptoms may become more noticeable when estrogenic activity remains high relative to progesterone, ovulation becomes inconsistent, estrogen metabolism or elimination is impaired, or hormone fluctuations become more pronounced.
The pattern often changes across the menstrual cycle. Some women notice symptoms primarily before their period, while others develop increasingly irregular cycles, heavier bleeding, migraines, sleep disruption, breast tenderness, anxiety, or metabolic changes that become less predictable over time.
Menstrual and Cycle Changes
Prolonged or relatively unopposed estrogenic stimulation can affect endometrial growth and menstrual-cycle patterns, particularly when ovulation is inconsistent and progesterone production is inadequate.
Common changes include:
Heavy or prolonged menstrual bleeding
Increased clotting during periods
Shortened or irregular cycles
Worsening PMS
More symptomatic periods
Increasing cycle variability during perimenopause
These patterns often reflect continued estrogenic stimulation without the normal progesterone response that follows consistent ovulation (3,12).
Anxiety, Irritability, and Mood Changes
Estrogen and progesterone interact with multiple neurotransmitter systems involved in mood, stress response, and emotional regulation. When hormone levels fluctuate rapidly or progesterone output becomes inadequate, women may experience:
Anxiety that intensifies during certain phases of the cycle
Increased irritability or emotional reactivity
Premenstrual mood changes
Low mood that tracks with cycle timing
Feeling unusually overstimulated or less resilient to stress
The timing of these symptoms matters. Mood changes that reliably follow particular phases of the menstrual cycle can provide important information about hormone fluctuation, ovulation, and progesterone production (5).
Sleep Disturbance and Fatigue
Hormone imbalance can also affect sleep and nervous-system regulation. Progesterone and its neuroactive metabolites interact with GABAergic signaling, while estrogen influences thermoregulation, neurotransmission, and circadian physiology (6).
Common patterns include:
Difficulty falling asleep
Frequent nighttime waking
Early-morning waking
Nighttime anxiety or feeling “wired”
Lighter, less restorative sleep
Daytime fatigue despite adequate time in bed
These symptoms can become particularly noticeable during anovulatory cycles and perimenopause, when progesterone production becomes less consistent and estrogen levels can fluctuate substantially.
Weight Gain, Cravings, and Blood Sugar Changes
Estrogen dominance frequently overlaps with insulin resistance, altered adipose signaling, and disrupted ovulation. The relationship works in both directions: metabolic dysfunction can interfere with ovulation and progesterone production, while increased adipose aromatase activity can increase peripheral conversion of androgen precursors into estrogens.
Women may notice:
Weight gain or increasing difficulty losing weight
Increased abdominal or lower-body fat accumulation
Premenstrual cravings
Energy crashes between meals
Blood sugar instability
Greater difficulty maintaining metabolic stability during perimenopause
These symptoms should be understood as part of the interaction between estrogen, progesterone, insulin, adipose tissue, and ovarian signaling, rather than as the result of estrogen alone (7).
Hormonal Headaches and Migraines
Estrogen fluctuations can affect vascular tone, serotonin signaling, trigeminal pain pathways, inflammatory signaling, and pain sensitivity. Rapid changes in estrogen—particularly around menstruation—are a well-recognized trigger for hormonally related headaches and migraines (18).
Common patterns include:
Migraines that occur before or during menstruation
Headaches that cluster around ovulation
Increasing migraine frequency during perimenopause
Headaches that worsen as cycles become more irregular
Greater sensitivity to other migraine triggers during hormonal shifts
For some women, the problem is not simply an elevated estrogen level but the magnitude and timing of estrogen fluctuation relative to progesterone and the rest of the cycle (18).
Breast Tenderness and Other Estrogen-Sensitive Symptoms
Breast tissue is highly responsive to reproductive hormones (19). Changes in estrogen and progesterone signaling can contribute to:
Premenstrual breast tenderness
Breast fullness or swelling
Increased sensitivity before menstruation
Cyclical fluid retention and bloating
These symptoms often become more pronounced when cycles are anovulatory, progesterone production declines, or hormone fluctuations intensify during perimenopause.
Why Estrogen Dominance Causes Symptoms Across Multiple Systems
Estrogen receptors are distributed throughout the brain, immune system, cardiovascular system, adipose tissue, liver, breast tissue, bone, and reproductive organs (4,8,9). A disruption in estrogen–progesterone balance therefore does not remain confined to the menstrual cycle.
In clinical practice, the combination and timing of symptoms often provides more information than any single complaint. Heavy periods accompanied by breast tenderness, insomnia, anxiety, migraines, weight changes, or worsening PMS point toward a hormone pattern that warrants a more detailed evaluation of:
Ovulation and progesterone production
Estrogen production and metabolite patterns
Estrogen methylation and conjugation
Gut-mediated estrogen recirculation
Thyroid and prolactin signaling
Insulin resistance and metabolic health
Liver and bowel elimination
Stress and cortisol physiology
Environmental and exogenous hormone exposure
The goal is to identify which mechanisms are driving the symptom pattern, rather than treating each symptom as an unrelated problem.
Additional Drivers of Estrogen Dominance
Estrogen dominance rarely develops from a single factor. In clinical practice, it often reflects stacked physiology—multiple systems influencing estrogen production, progesterone output, metabolism, recirculation, elimination, and tissue-level signaling at the same time.
These additional drivers can significantly change how estrogen is produced, processed, and experienced throughout the body.
The Estrobolome and Estrogen Recirculation
The gut plays a direct role in estrogen regulation through the estrobolome—the collection of intestinal microbial genes involved in estrogen metabolism (15).
After estrogen is metabolized and conjugated in the liver, a portion is excreted into bile and enters the intestine. Gut microbial enzymes, particularly β-glucuronidases and sulfatases, can deconjugate these estrogen metabolites and allow biologically active estrogens to be reabsorbed into circulation rather than eliminated (15).
This enterohepatic recycling can meaningfully influence systemic estrogen exposure. When bowel transit is slow, microbial balance is disrupted, or β-glucuronidase activity is elevated, estrogen elimination can become less efficient and recirculation can increase.
From a functional medicine perspective, this becomes particularly relevant when hormone symptoms coexist with:
Constipation or infrequent bowel movements
Bloating or altered bowel habits
Dysbiosis
Chronic gastrointestinal inflammation
Extensive antibiotic exposure
Impaired bile flow or digestive dysfunction
The gut therefore functions as an important part of estrogen clearance rather than as a separate system unrelated to hormone balance.
Insulin Resistance, Metabolic Dysfunction, and Adipose Aromatase
Metabolic health strongly influences estrogen balance through several pathways.
Insulin resistance can interfere with ovarian signaling and ovulation, reducing progesterone production and shifting the estrogen–progesterone relationship. At the same time, adipose tissue functions as an endocrine organ and expresses aromatase, the enzyme that converts androgen precursors into estrogens (7).
Greater adipose mass can therefore increase peripheral estrogen production while metabolic dysfunction simultaneously disrupts ovulatory function.
Key mechanisms include:
Increased peripheral aromatization of androgens to estrogens
Disrupted ovulation and lower luteal progesterone output
Altered insulin and ovarian signaling
Increased inflammatory signaling
Changes in adipokines and metabolic hormone regulation (7)
This is one reason estrogen-dominant patterns frequently overlap with weight gain, difficulty losing weight, cravings, fatigue, blood sugar instability, and worsening hormone symptoms during periods of metabolic dysfunction.
Hormonal Contraceptives and Exogenous Hormone Exposure
Hormonal contraceptives intentionally alter hypothalamic-pituitary-ovarian signaling and suppress or modify ovulation while they are being used. They also introduce synthetic hormones that change endogenous estrogen and progesterone physiology.
After discontinuation, the return of regular ovulatory cycles varies considerably between women. In some cases, previously masked patterns such as PCOS, hypothalamic dysfunction, thyroid imbalance, insulin resistance, or pre-existing cycle irregularity become more apparent.
A history of hormonal contraception is therefore relevant when evaluating:
Current ovulatory function
Progesterone production
Cycle regularity
Hormone-binding patterns
Androgen signaling
Symptoms that emerged or changed after starting or stopping hormonal contraception (20)
Exogenous estrogen exposure from hormone therapy or other medications should also be considered alongside endogenous hormone production, metabolism, and elimination (10,20).
Nutrient and Genetic Influences on Estrogen Metabolism
Estrogen metabolism depends on multiple enzyme systems and nutrient-dependent biochemical pathways, including:
hydroxylation
methylation
glucuronidation
sulfation
antioxidant protection of catechol estrogen metabolism (10,16)
Nutrient status can therefore influence how efficiently estrogen metabolites move through these pathways. Clinically relevant nutrients can include methyl donors and cofactors involved in phase II metabolism, antioxidant defense, hepatic function, and intestinal elimination.
Genetic variants can add another layer of information. Variations involving pathways such as COMT, MTHFR, CYP enzymes, GST enzymes, and other detoxification-related genes can influence estrogen metabolism, methylation capacity, oxidative stress handling, and sensitivity to environmental or endogenous hormone burden (21).
These genetic patterns are most useful when interpreted alongside:
Estrogen metabolite patterns
Methylation status and nutrient sufficiency
Liver function
Oxidative stress
Gut function and elimination
Environmental exposures
Metabolic health
The patient’s symptom pattern
Genetics do not act in isolation. They help explain why two women with similar hormone levels or environmental exposures can process estrogen very differently (16,21).
Health Conditions Associated With Estrogen Dominance
When estrogenic signaling remains elevated relative to progesterone—or when estrogen metabolism, elimination, or ovulation remain disrupted over time—the effects can extend beyond cyclical symptoms. Estrogen-responsive tissues, metabolic signaling, inflammatory pathways, and reproductive function can all be affected.
The relationship differs by condition. In some cases, such as endometrial hyperplasia, prolonged estrogen stimulation without adequate progesterone opposition is a direct physiological driver. In others, estrogen interacts with progesterone, insulin, inflammatory signaling, growth factors, genetics, and local tissue metabolism as part of a more complex process.
Uterine Fibroids and Estrogen-Progesterone Signaling
Uterine fibroids are strongly hormone responsive. Estrogen promotes cellular proliferation and progesterone-receptor expression, while progesterone signaling also contributes substantially to fibroid growth, extracellular-matrix production, and tissue remodeling (22).
Fibroid biology therefore reflects an interaction between estrogen, progesterone, growth factors, inflammatory signaling, genetics, and local tissue metabolism rather than estrogen acting in isolation.
From a functional medicine perspective, relevant contributors can include:
Estrogen and progesterone balance
Ovulatory function
Insulin resistance and metabolic dysfunction
Adipose aromatase activity
Estrogen metabolism and elimination
Inflammatory signaling
Environmental endocrine exposures
Endometrial Hyperplasia and Unopposed Estrogen
The endometrium is particularly sensitive to the balance between estrogen and progesterone. Estrogen stimulates endometrial proliferation during the first half of the menstrual cycle, while progesterone after ovulation changes the tissue toward secretory maturation (3).
When ovulation is absent or progesterone production remains inadequate, continued estrogenic stimulation can promote excessive endometrial growth. Chronic anovulation, PCOS, insulin resistance, increased adiposity, and exogenous estrogen exposure can all contribute to this pattern (3,7,20).
This is one of the clearest examples of why progesterone opposition and consistent ovulation matter, rather than focusing on estradiol levels alone.
Cyclical Breast Tenderness and Hormone-Sensitive Breast Tissue
Breast tissue responds to both estrogen and progesterone. Changes in hormone concentration, receptor signaling, fluid retention, and inflammatory activity can contribute to cyclical breast tenderness, fullness, swelling, and increased premenstrual sensitivity (19).
These symptoms often become more pronounced during periods of greater hormone fluctuation, inconsistent ovulation, or declining progesterone production, particularly during perimenopause.
PCOS, Insulin Resistance, and Chronic Anovulation
PCOS can create a strong estrogen-dominant pattern through several overlapping mechanisms.
When ovulation is irregular or absent, normal luteal progesterone production is reduced. At the same time, insulin resistance can increase ovarian androgen production, alter SHBG, disrupt follicular development, and interfere with normal ovulatory signaling (7).
Increased adipose aromatase activity can further convert androgen precursors into estrogens, creating a pattern of ongoing estrogen exposure with inadequate progesterone opposition.
This is why PCOS frequently requires simultaneous attention to:
Insulin sensitivity
Ovulatory function
Androgen balance
SHBG
Estrogen metabolism
Inflammation
Weight and adipose signaling
Thyroid and adrenal influences
Estrogen Exposure and Hormone-Sensitive Cancer Risk
Estrogen signaling is an important part of the biology of several hormone-sensitive cancers, although the mechanisms differ substantially between tissues.
For the endometrium, prolonged estrogen stimulation without adequate progesterone opposition can increase endometrial proliferation and long-term risk (3).
Breast tissue is more complex. Estrogen-receptor signaling interacts with progesterone signaling, genetics, lifetime reproductive hormone exposure, metabolic health, insulin signaling, inflammatory pathways, environmental exposures, alcohol intake, and local tissue metabolism (23).
From a functional medicine perspective, hormone-related cancer risk therefore belongs within a broader assessment of:
metabolic health
estrogen exposure and metabolism
inflammation
environmental burden
insulin regulation
body composition
reproductive history
rather than being reduced to one estrogen value.
Thyroid Dysfunction and Estrogen Balance
Thyroid and reproductive hormones are closely interconnected. Thyroid dysfunction can alter menstrual regularity, ovulation, SHBG, energy metabolism, body weight, and progesterone production, while estrogen influences thyroid-binding proteins and peripheral hormone physiology (13).
This overlap can contribute to symptoms such as:
Heavy or irregular periods
Fatigue
Weight gain
Mood changes
Poor temperature regulation
Reduced ovulatory function
Fertility difficulties
For this reason, thyroid function is an important part of a functional hormone evaluation when estrogen-dominant symptoms are present.
When Estrogen-Dominant Symptoms Point to a More Complex Pattern
Estrogen-dominant symptoms should be interpreted in the context of the entire clinical picture. Heavy bleeding, pelvic pain, rapidly changing cycle patterns, persistent breast changes, or new postmenopausal bleeding can indicate that more than hormone imbalance alone is contributing.
The goal is not to separate “functional” symptoms from other pathology, but to understand how hormone signaling, metabolic health, structural changes, inflammation, and tissue-level processes are interacting in the same patient.
Testing for Estrogen Dominance
Estrogen dominance is assessed as a physiological pattern, not through one isolated hormone value. A detailed functional hormone evaluation looks at estrogen production, progesterone output, ovulatory function, estrogen metabolites, methylation and conjugation pathways, cortisol physiology, metabolic health, gut-mediated estrogen recirculation, nutrient status, and environmental hormone exposure.
This level of detail matters because women with similar symptoms can have very different underlying patterns. One woman may have inadequate progesterone because she is not ovulating consistently. Another may have altered estrogen metabolism or methylation. Another may have significant metabolic dysfunction, increased enterohepatic recycling, or environmental endocrine exposure contributing to the overall estrogenic burden.
Why Serum Estradiol and Progesterone Alone Are Incomplete
Serum estradiol and progesterone have significant limitations when used alone to evaluate estrogen dominance because reproductive hormones fluctuate substantially across the menstrual cycle. A single blood draw captures hormone concentrations at one moment in time and can miss important changes in ovulation, luteal progesterone output, and estrogen metabolism.
Estradiol alone also does not show the complete estrogen picture. It does not assess:
Estrone or estriol
2-hydroxy, 4-hydroxy, and 16-hydroxy estrogen metabolites
Catechol estrogen methylation
Methoxy-estrogen metabolites
Progesterone metabolites
Estrogen conjugation and downstream clearance patterns
Diurnal cortisol and cortisone patterns
Total metabolized cortisol output
For this reason, isolated serum estradiol and progesterone measurements are often inadequate for understanding the physiology behind an estrogen-dominant pattern.
Blood testing is more useful for evaluating related endocrine and metabolic systems. Depending on the presentation, I commonly assess:
TSH, free T4, free T3, TPO antibodies, and thyroglobulin antibodies
Prolactin
Sex hormone-binding globulin (SHBG)
Total testosterone
Free testosterone
Fasting insulin
Fasting glucose
Hemoglobin A1c
Additional cardiometabolic and inflammatory markers
These markers can identify thyroid dysfunction, hyperprolactinemia, insulin resistance, altered androgen signaling, and changes in hormone binding that can disrupt ovulation and the broader estrogen–progesterone relationship.
Serum testing provides a single-time-point concentration of selected hormones; urinary metabolite testing provides a more detailed picture of hormone production, metabolism, downstream metabolites, and elimination.
DUTCH Testing for Estrogen Metabolism, Progesterone, and Cortisol Patterns
For a more detailed assessment of estrogen physiology, dried urine hormone testing such as DUTCH provides information that standard serum estradiol and progesterone testing does not.
DUTCH testing can evaluate:
Estrone, estradiol, and estriol
2-hydroxy estrogen metabolites
4-hydroxy estrogen metabolites
16-hydroxy estrogen metabolites
Methoxy-estrogen metabolites
Progesterone metabolites
Androgen production and metabolism
Free cortisol and cortisone rhythm
Metabolized cortisol
Total cortisol production and clearance
Selected organic-acid markers relevant to hormone metabolism, depending on the panel
Estrogen metabolism can be examined through the 2-hydroxy, 4-hydroxy, and 16-hydroxy pathways, along with methoxy-estrogen metabolites that provide information about downstream methylation of catechol estrogens.
Progesterone metabolites add important information about luteal hormone production, while androgen metabolites and cortisol patterns help place reproductive hormones within the larger endocrine and stress-physiology picture.
This level of detail can distinguish women who look very similar based on symptoms alone. One may have inadequate progesterone output from inconsistent ovulation. Another may show altered estrogen hydroxylation or methylation. Another may have significant cortisol dysregulation, altered androgen metabolism, or several overlapping patterns requiring a different treatment strategy.
What a Functional Hormone Assessment Evaluates
A functional hormone evaluation looks beyond isolated hormone concentrations and examines how multiple regulatory systems are interacting.
Estrogen Production and Metabolism
Evaluation includes estrone, estradiol, estriol, estrogen metabolites, hydroxylation patterns, downstream methylation, and the balance between estrogen production, metabolism, and elimination.
Progesterone and Ovulatory Function
Because progesterone production depends on ovulation, I look at whether ovulation is occurring consistently and whether luteal progesterone output is adequate relative to estrogenic stimulation.
Thyroid and Prolactin
TSH, free T4, free T3, thyroid antibodies, and prolactin can identify endocrine patterns that interfere with ovulation, menstrual-cycle regulation, metabolism, and hormone signaling.
Androgen Signaling
Total testosterone, free testosterone, SHBG, and androgen metabolites help identify PCOS, insulin-related hormone changes, altered androgen production, and hormone-binding abnormalities.
Cortisol and Stress Physiology
Diurnal free cortisol and cortisone, metabolized cortisol, and total cortisol output provide a more detailed view of HPA-axis activity, cortisol production, and clearance than a single morning cortisol measurement.
Metabolic Regulation
Fasting insulin, glucose, HbA1c, adiposity, inflammatory signaling, and broader cardiometabolic markers help identify metabolic factors that can disrupt ovulation, alter aromatase activity, and change estrogen–progesterone balance.
Gut Function and Estrogen Recirculation
Constipation, dysbiosis, altered microbial β-glucuronidase activity, bile flow, and enterohepatic recycling can influence how effectively estrogen is eliminated versus reabsorbed.
Nutrient Status and Methylation Capacity
Estrogen metabolism depends on nutrient-dependent pathways involved in methylation, conjugation, antioxidant defense, and hepatic metabolism. Deficiencies can alter how estrogen metabolites are processed and cleared.
Environmental and Exogenous Hormone Exposure
Endocrine-disrupting chemicals, hormonal contraceptives, hormone therapy, medications, and other exogenous exposures can alter estrogen signaling, metabolism, and total endocrine burden.
Why Detailed Functional Hormone Testing Matters
The purpose of testing is not simply to determine whether estrogen falls inside a reference range. It is to identify where hormone regulation is breaking down.
A woman with inconsistent ovulation and low progesterone requires a different strategy from someone with altered estrogen metabolism, impaired methylation, insulin resistance, increased enterohepatic recycling, cortisol dysregulation, or substantial environmental hormone exposure.
Detailed testing allows treatment to be directed at the physiology actually driving the pattern rather than applying the same hormone protocol to every woman with similar symptoms.
Functional Medicine Treatment for Estrogen Dominance
Functional medicine treatment for estrogen dominance focuses on identifying and correcting the mechanisms driving the imbalance, rather than simply attempting to lower estrogen.
Depending on the pattern, treatment may target disrupted ovulation, inadequate progesterone production, altered estrogen metabolism, impaired methylation or conjugation, increased enterohepatic recycling, insulin resistance, gut dysfunction, stress physiology, or environmental endocrine exposure.
The treatment strategy changes according to which of these mechanisms are actually contributing.
Restore Ovulation and Progesterone Production
Because progesterone production depends on successful ovulation, restoring consistent ovulatory function is foundational when low progesterone is part of the pattern.
Treatment may focus on:
Improving insulin sensitivity and blood sugar regulation
Correcting inadequate caloric or nutrient intake
Reducing excessive training or physiologic stress
Supporting sleep and circadian rhythm
Addressing thyroid dysfunction or hyperprolactinemia
Improving metabolic and ovarian signaling in PCOS
Supporting more consistent ovulation during perimenopausal transition when appropriate
When ovulation improves, luteal progesterone production can increase naturally, restoring a more balanced relationship between estrogenic stimulation and progesterone opposition.
Acupuncture for Hormonal Regulation and Ovulatory Support
Acupuncture can be an important part of a functional hormone treatment plan when estrogen dominance overlaps with disrupted ovulation, menstrual pain, hormonally triggered headaches, sleep disturbance, autonomic dysregulation, or chronic stress physiology.
Its effects extend beyond symptom control through neuroendocrine and autonomic pathways involved in hypothalamic-pituitary-ovarian signaling, stress regulation, circulation, pain processing, and reproductive function.
Acupuncture may be used to:
Support ovulatory regulation
Support luteal-phase hormone function
Reduce menstrual pain and hormonally triggered headaches
Improve sleep and autonomic regulation
Reduce physiologic stress load
Support digestive function and bowel regularity
Improve overall responsiveness to a broader hormone treatment plan
Acupuncture is most effective when integrated with the rest of the functional assessment rather than used as an isolated treatment for estrogen itself.
Support Estrogen Detoxification, Metabolism, and Elimination
Estrogen detoxification is a biochemical process involving phase I metabolism, phase II conjugation, methylation, glucuronidation, sulfation, biliary excretion, urinary elimination, and intestinal clearance.
Treatment is directed at the specific pathway that needs support rather than applying a generic “detox” protocol.
Clinical priorities may include:
Supporting phase I estrogen hydroxylation
Supporting methylation of catechol estrogens
Supporting glucuronidation and sulfation
Correcting nutrient deficiencies involved in conjugation pathways
Supporting liver and bile function
Promoting regular bowel elimination
Reducing factors that increase estrogen recirculation
When metabolism and elimination improve, the body is better able to process and clear estrogen metabolites efficiently.
Address Gut Health and Estrogen Recirculation
Because a portion of estrogen is eliminated through bile into the intestine, gut function directly influences estrogen clearance.
An altered estrobolome, elevated microbial β-glucuronidase or sulfatase activity, constipation, dysbiosis, and impaired bowel transit can increase deconjugation and enterohepatic recirculation of estrogen.
Treatment may include:
Restoring regular bowel movements
Addressing constipation and slow transit
Correcting dysbiosis
Reducing gastrointestinal inflammation
Supporting microbial balance
Supporting bile flow and digestive function
Addressing factors that increase β-glucuronidase activity
Improving intestinal elimination can reduce the amount of estrogen that is deconjugated and returned to circulation.
Reduce Xenoestrogen and Endocrine-Disrupting Chemical Exposure
Environmental endocrine exposure can add to total estrogenic and endocrine signaling burden while also influencing hormone synthesis, receptor activity, metabolism, and clearance.
Strategies may include:
Reducing plastic and food-packaging exposure
Limiting bisphenols and phthalates
Choosing lower-toxin personal care and household products
Improving water quality
Reducing pesticide and herbicide exposure
Identifying occupational or environmental exposures
Reviewing exogenous hormone and medication exposure
Lowering cumulative endocrine-disrupting exposure reduces one source of hormone signaling that the body must continually regulate and metabolize.
Improve Insulin Sensitivity and Metabolic Regulation
Insulin resistance can disrupt ovulation, alter ovarian signaling, reduce progesterone production, and increase peripheral estrogen production through adipose aromatase activity.
Treatment may focus on:
Improving insulin sensitivity
Stabilizing glucose and insulin patterns
Increasing protein and fiber intake where appropriate
Reducing highly refined carbohydrate exposure
Improving meal timing
Increasing skeletal-muscle glucose utilization
Addressing excess adiposity when it is contributing to aromatase activity
Reducing inflammatory metabolic burden
Improving metabolic function can support more consistent ovulation while simultaneously reducing one source of excess peripheral estrogen production.
Use Targeted Nutrients and Botanical Medicine
Targeted nutrients and botanical medicine can be foundational components of treatment when they are matched to the physiology identified through symptoms, history, and testing.
Depending on the pattern, treatment may target:
Estrogen hydroxylation
Catechol estrogen methylation
Phase II conjugation
Liver and bile function
Gut microbial balance
β-glucuronidase activity
Insulin sensitivity
Oxidative stress
Ovulatory signaling
Progesterone support
HPA-axis and autonomic regulation
Nutrients and botanicals are selected according to the pathway involved rather than prescribed as a generic “estrogen detox” protocol. A woman with disrupted ovulation requires a different strategy from someone whose primary issue is impaired methylation, constipation, insulin resistance, or environmental endocrine burden.
Treat the Mechanism, Not the Label
Estrogen dominance is most effectively addressed by identifying where hormone regulation is breaking down.
The central questions are:
Is ovulation occurring consistently?
Is progesterone production adequate?
Is estrogen production excessive?
Are estrogen metabolites moving through favorable pathways?
Is methylation adequate?
Is enterohepatic recycling increasing estrogen exposure?
Is insulin resistance contributing?
Is gut dysfunction impairing elimination?
Are environmental or exogenous hormone exposures adding to the burden?
The answers determine the treatment strategy.
Functional medicine treatment is therefore not focused on suppressing estrogen. It is focused on restoring ovulatory function, hormone metabolism, elimination, metabolic regulation, gut function, and neuroendocrine balance so estrogen can function within a more stable physiological system.
A Root-Cause Approach to Estrogen Dominance
Estrogen dominance is not one hormone problem with one treatment. It can develop through inconsistent ovulation and low progesterone, altered estrogen metabolism, impaired elimination, insulin resistance, gut-mediated estrogen recirculation, environmental endocrine exposure, stress physiology, or several of these mechanisms at the same time.
Effective treatment starts by identifying which pathways are driving the imbalance. That may mean restoring ovulation, improving progesterone production, supporting estrogen metabolism and methylation, reducing enterohepatic recycling, correcting metabolic dysfunction, improving gut elimination, or reducing environmental hormone burden.
For women with persistent PMS, heavy or irregular periods, breast tenderness, migraines, sleep disruption, anxiety, weight changes, or increasingly unpredictable cycles, detailed hormone testing can help clarify why the pattern is occurring and which treatment targets are most relevant.
→ Hormone & Metabolic Optimization
Frequently Asked Questions About Estrogen Dominance
What is estrogen dominance?
Estrogen dominance is a functional hormone pattern in which estrogenic influence is excessive relative to progesterone or remains elevated because estrogen production, metabolism, recirculation, or elimination are out of balance. It can occur even when a single estradiol measurement falls within the laboratory reference range.
What are the most common symptoms of estrogen dominance?
Common symptoms include heavy or prolonged periods, worsening PMS, breast tenderness, irregular cycles, anxiety or irritability that changes with the menstrual cycle, sleep disruption, hormonal headaches or migraines, bloating, weight changes, cravings, and fatigue. Symptoms often occur in clusters rather than as one isolated complaint.
Can you have estrogen dominance with normal estrogen levels?
Yes. Estrogen dominance does not always mean estradiol itself is elevated. A woman can have relatively greater estrogenic activity because progesterone production is inadequate, ovulation is inconsistent, estrogen metabolism is altered, or estrogen is being recirculated rather than efficiently eliminated.
What is the difference between high estrogen and estrogen dominance?
High estrogen refers to estrogen concentrations that are elevated for the relevant age, cycle phase, or physiological context. Estrogen dominance is a broader functional pattern that can involve high estrogen, inadequate progesterone, disrupted ovulation, altered estrogen metabolism, or increased estrogen recirculation.
Can perimenopause cause estrogen dominance?
Perimenopause commonly creates estrogen-dominant patterns because ovulation becomes less consistent and progesterone production can decline while estrogen remains substantial or fluctuates widely. This can contribute to heavier periods, worsening PMS, breast tenderness, migraines, sleep disruption, anxiety, and increasingly unpredictable cycles.
How does low progesterone contribute to estrogen dominance?
Progesterone production depends on successful ovulation. When ovulation is delayed, inconsistent, or absent, luteal progesterone output falls while estrogenic stimulation may continue. The resulting imbalance can contribute to heavier bleeding, worsening PMS, breast tenderness, sleep disruption, anxiety, and hormonally triggered headaches.
How does gut health affect estrogen dominance?
A portion of metabolized estrogen enters the intestine through bile. Gut microbial enzymes such as beta-glucuronidase and sulfatase can deconjugate estrogen metabolites and allow biologically active estrogen to be reabsorbed into circulation. Constipation, dysbiosis, altered microbial activity, and impaired bowel elimination can therefore increase enterohepatic estrogen recycling.
Can insulin resistance contribute to estrogen dominance?
Yes. Insulin resistance can disrupt ovulation and reduce progesterone production while also altering ovarian and metabolic signaling. Increased adipose tissue can further increase aromatase activity, which converts androgen precursors into estrogens. Metabolic dysfunction can therefore influence estrogen balance through several pathways at once.
What is the best way to test for estrogen dominance?
Estrogen dominance is best evaluated as a physiological pattern rather than through one isolated estradiol or progesterone measurement. A detailed functional hormone assessment may include dried urine hormone metabolites, ovulatory and cycle patterns, thyroid markers, prolactin, SHBG, total and free testosterone, insulin and glucose regulation, gut function, nutrient status, and environmental or exogenous hormone exposure.
What does DUTCH testing show for estrogen dominance?
DUTCH testing provides a detailed view of estrone, estradiol, estriol, estrogen metabolites, progesterone metabolites, androgen metabolites, and cortisol patterns. It can show 2-hydroxy, 4-hydroxy, and 16-hydroxy estrogen pathways, downstream methylation of catechol estrogens, luteal progesterone output, and cortisol production and metabolism that are not visible on a single serum estradiol or progesterone measurement.
How is estrogen dominance treated with functional medicine?
Functional medicine treatment targets the mechanisms driving the imbalance. Treatment may focus on restoring ovulation and progesterone production, improving insulin sensitivity, supporting estrogen detoxification and methylation, reducing enterohepatic recycling, improving gut and bowel function, reducing endocrine-disrupting chemical exposure, and using targeted nutrition, botanical medicine, nutraceuticals, and acupuncture based on the individual hormone pattern.
Still Have Questions?
If the topics above reflect ongoing symptoms or unanswered concerns, a brief conversation can help clarify whether a root-cause approach is appropriate.
Resources
Endocrinology - Unconventional Estrogen Signaling in Health and Disease
Steroids - What are the physiological estrogens?
Cochrane Database of Systematic Reviews - Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer
Nature Reviews Endocrinology - The G protein-coupled estrogen receptor GPER in health and disease
Seminars in Reproductive Medicine - Mechanisms of Action of Estrogen in the Brain: Insights from Human Neuroimaging and Psychopharmacologic Studies
The Journal of Clinical Endocrinology & Metabolism - Efficacy of Micronized Progesterone for Sleep: A Systematic Review and Meta-analysis of Randomized Controlled Trial Data
Journal of Ovarian Research - Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
Endocrine Reviews - Estrogen Receptor Signaling in the Immune System
Endocrinology - Estrogen and the Vascular Endothelium: The Unanswered Questions
The Journal of Steroid Biochemistry and Molecular Biology - Metabolism of endogenous and exogenous estrogens in women
BMC Chemistry - Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC-MS/MS)
Clinical Obstetrics and Gynecology - A Clinician's Guide to Functional Hypothalamic Amenorrhea
International Journal of Molecular Sciences - The Thyroid Hormone Axis and Female Reproduction
Obstetrics and Gynecology Clinics of North America - Reproductive Hormones and the Menopause Transition
The Journal of Steroid Biochemistry and Molecular Biology - Estrobolome: Is there a missing link?
Cancer Research - Catechol-O-Methyltransferase (COMT)-mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms
Nature Reviews Endocrinology - Endocrine-disrupting chemicals and female reproductive health: a growing concern
The Journal of Headache and Pain - Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
Surgical Clinics of North America - Management of Mastalgia
Contraception and Reproductive Medicine - Return of fertility after discontinuation of contraception: a systematic review and meta-analysis
Cancer Epidemiology, Biomarkers & Prevention - Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk
The Journal of Steroid Biochemistry and Molecular Biology - Progesterone and estrogen signaling in uterine fibroids: A tale of two interconnected pathways
Frontiers in Oncology - Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk